Lung Diseases: all 3,319 studies

Page 29 of 34. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.

• A Pilot Study of Pulmonary Function in Dysphagic InfantsCompletedNCT00831038Not applicable
• Water- and Salt-homeostasis in Healthy Humans, and in Patients With Heart- or Lung DiseaseStatus unknownNCT00830726
• A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic SubjectsWithdrawnNCT00830427Phase 2
• Anti-inflammatory Effects of Caffeine in Chronic Obstructive Pulmonary Disease (COPD) SubjectsWithdrawnNCT00826566Not applicable
• Innate Immune Responses in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00826163Phase 3
• Efficacy of Arm Training in COPD PatientsCompletedNCT00825032Not applicable
• Assessment of Treatment With PulseHaler on Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00821418Not applicable
• Biomarkers in Pulmonary Hypertension Associated to Interstitial Lung DiseaseCompletedNCT00820729
• Comparing Methods for Tracking Health Information at Home After Lung TransplantCompletedNCT00818025Not applicable
• Added Value of inReach Software on Performance Characteristics of Standard BronchoscopyCompletedNCT00817167Not applicable
• Application and Generalization of Flutter Mucus Clearance DeviceCompletedNCT00816881Not applicable
• Idiopathic Pulmonary Fibrosis Registry for Future StudiesCompletedNCT00815711
• A Registry of COPD Patients to be Used for Future StudiesCompletedNCT00814203
• Sedation Management in Pediatric Patients With Acute Respiratory Failure (The RESTORE Study)CompletedNCT00814099Not applicable
• A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.CompletedNCT00808288Phase 2
• Sensitivity of New Exercise Tests in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00807534Not applicable
• End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)Status unknownNCT00792974
• Antibiotic/COPD in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) Requiring Mechanical VentilationCompletedNCT00791505Phase 3
• Surfactant Disorders and Chronic Lung DiseaseCompletedNCT00783978
• Bronchodilators and Respiratory Mechanics in Chronic Obstructive Pulmonary Disease (COPD) PatientsTerminatedNCT00783250Phase 4
• Aerosol Cyclosporine in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00783107Phase 1
• Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00782535Phase 2
• Does Pulmonary Rehabilitation Change Self-Selected And Maximum Sustainable Walking Speed In Patients With Lung Disease?CompletedNCT00781183Not applicable
• A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00774761Phase 2
• Pennsylvania Study Of Chronic Obstructive Pulmonary ExacerbationsCompletedNCT00774176
• Magnetic Resonance Imaging (MRI) for Early Diagnosis of Cystic Fibrosis (CF)CompletedNCT00760071
• Analyzing Lung Tissue in People With and Without Chronic Obstructive Pulmonary Disease Who Are Undergoing Lung TransplantationCompletedNCT00756522
• Effectiveness of Home Automated Telemanagement in Chronic Obstructive Pulmonary DisorderCompletedNCT00752531Not applicable
• A Phase 1b Study to Evaluate the Safety and PK of MP-376 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00752414Phase 1
• Lung Allograft Rejection Gene Expression Observational (LARGO) StudyTerminatedNCT00751309
• Beta-Blocker in Chronic Obstructive Pulmonary Disease (COPD) StudyCompletedNCT00745043Not applicable
• Use Of Capnography As Surrogate Measure Of PC02 In Medical Intensive Care Unit (ICU) PatientsTerminatedNCT00744614
• A 12 Week Physical Training Programme for Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00744484Not applicable
• Formoterol Via pMDI HFA-134a Propellant or DPI in Partially Reversible Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00742248Phase 2
• The Effects of a Positive Expiratory Pressure (PEP) on Dyspnea and Dynamic Hyperinflation During Exercise in Chronic Obstructive Pulmonary Disease (COPD) PatientsStatus unknownNCT00741832Not applicable
• The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPDWithdrawnNCT00741767Not applicable
• Individual Sensitivity for Interstitial Lung DiseasesCompletedNCT00741572
• Factors That Affect the Development of COPD SymptomsCompletedNCT00740337
• Coping Skills for Patients With Chronic Obstructive Pulmonary Disease (COPD) and Their CaregiversCompletedNCT00736268Not applicable
• EUROPT Clinical Trial to Study the Efficacy of One-Way Valve Implantation (New Treatment Algorithm) in Patients With Heterogeneous EmphysemaStatus unknownNCT00730301Phase 4
• Evaluating Genetic Factors That May Contribute to Elastin Function and the Development of Chronic Obstructive Pulmonary DiseaseCompletedNCT00725309
• Long-term Lung Function and Disease Progression in Children With Early Onset Primary Ciliary Dyskinesia Lung DiseaseCompletedNCT00722878
• European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00722267
• Vibration Response Imaging in the Diagnosis of Pulmonary DiseaseCompletedNCT00719784Not applicable
• Non-invasive Ventilation in Severe Chronic Obstructive Pulmonary Disease(COPD)TerminatedNCT00710541Not applicable
• Patient Education in Patients With Chronic Obstructive Pulmonary Disease (COPD) - Effect and CostsCompletedNCT00705302Not applicable
• Bisoprolol in Patients With Heart Failure and Chronic Obstructive Pulmonary DiseaseTerminatedNCT00702156Phase 2
• Lovastatin as a Potential Modulator of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00700921Phase 2
• The Prevalence of Gastro-oesophageal Reflux in Chronic Lung DiseaseCompletedNCT00697177
• Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary FibrosisTerminatedNCT00690885Phase 2
• Improving Clinician Communication Skills (ICCS)CompletedNCT00687349Phase 3
• A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00685841Phase 3
• Evaluating Quality of Life for Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Lung TransplantationTerminatedNCT00675376
• Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary DiseaseCompletedNCT00672802Phase 2
• Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00671073Phase 2
• LTOT in COPD Patients With Moderate Chronic Hypoxemia and Chronic Heart FailureStatus unknownNCT00668408Phase 4
• Vitamin D as Treatment for Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00666367Phase 4
• Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00665600Phase 3
• Pharmacovigilance Study to Evaluate Safety of SERETIDE in Participants With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00662805
• Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT00662740Phase 3
• Functional Tests in Individuals With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00660738
• Effective High Aerobic Intensity Endurance Training Regimes in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00658853Not applicable
• Osteoprotegerin (OPG) in Induced Chronic Obstructive Pulmonary Disease (COPD) SputumCompletedNCT00655954
• Genomic/ Proteomic/ Metabonomic Profiling in Chronic Obstructive Pulmonary Disease (COPD)WithdrawnNCT00655694
• Community Based Self Management of COPD Facilitated by a Palliative Care Team:Impact on Health Care Utilization and QOLCompletedNCT00648609
• Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPDCompletedNCT00648245Phase 2
• A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00642148Phase 2
• Effectiveness and Safety of Inhaling Hypertonic Saline in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00639236Phase 4
• Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment StudyStatus unknownNCT00637065Phase 4
• Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT)WithdrawnNCT00633776Phase 4
• Breath Analysis by Ion Mobility SpectrometryStatus unknownNCT00632307
• Early Rehabilitation of COPD Patients in ICUTerminatedNCT00628992Not applicable
• Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With SildenafilWithdrawnNCT00625079Phase 4
• Using Furosemide to Prevent Fluid Overload During Red Blood Cell Transfusion in NeonatesStatus unknownNCT00618852Phase 3
• Inert Dusts and Pathology of Chronic Obstructive Pulmonary DiseaseCompletedNCT00618137
• Symbicort in Chronic Obstruktive Pulmonary DiseaseCompletedNCT00612976
• Symbicort in Chronic Obstructive Pulmonary DiseaseCompletedNCT00611520
• Dose Finding Study of CHF 4226 for Treating Patients With COPDCompletedNCT00605891Phase 2
• Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary DiseaseCompletedNCT00601055Not applicable
• Tigecycline for Treatment of Rapidly Growing MycobacteriaCompletedNCT00600600Phase 2
• Azithromycin in the Treatment of M. Avium Complex Lung DiseaseCompletedNCT00599079Phase 4
• Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung DiseaseCompletedNCT00598962Phase 4
• Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung DiseaseCompletedNCT00598897Phase 4
• Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPDCompletedNCT00583986Phase 3
• Study of Erythropoietin to Treat Anemia Complicating Chronic Obstructive Pulmonary DiseaseWithdrawnNCT00579046Phase 3
• Effect of Pressure Support Ventilation and Neurally Adjusted Ventilatory Assist (NAVA) in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00568100Not applicable
• Very Early Surfactant and NCPAP for Premature Infants With RDSCompletedNCT00563641Phase 3
• Iloprost in Gas Exchange/Pulm Mechanics in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00561223Not applicable
• A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).CompletedNCT00559910Phase 2
• Chronic Obstructive Pulmonary Disease (COPD) Outpatient on Demand ClinicCompletedNCT00556816Not applicable
• Study To Evaluate Safety And Tolerability Of GSK256066 In Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00549679Phase 2
• Treatment Of Partial Reversible Chronic Obstructive Pulmonary DiseaseCompletedNCT00549146Phase 3
• Cognitive Behavioral Therapy for Anxiety and Depression in COPDCompletedNCT00545922Phase 2
• Safety and Tolerability of Multiple Inhaled NVA237 Doses in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00545311Phase 1
• The Effects of a Home Exercise Video Programme for Patients With COPDCompletedNCT00542932Phase 2
• Vibration Response Imaging in Chronic Obstructive Pulmonary Disease and AsthmaCompletedNCT00542282
• Monitoring Asthma and COPD in Primary CareCompletedNCT00542061Not applicable
• Observational Non-interventional Study With Spiriva in Chronic Obstructive Pulmonary Disease Patients With Exercise-induced DyspnoeaCompletedNCT00540163
• Does PEP Compensate the Reduction of Tidal Volume During One Lung Ventilation?CompletedNCT00534690Not applicable
• Safety and Tolerability QAT370 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00532350Phase 1

← Lung Diseases overview